Get the latest tech news

Oura valued at $5B following deal with medical device firm Dexcom


Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

The partnership paves the way for the two companies’ devices and apps to be used together, which means Oura rings will eventually help users monitor their blood sugar. “This partnership with Dexcom will enable us to empower our members to make informed decisions and adjust behaviors to positively impact their biometrics and long-term health.” The report states that although Apple doesn’t plan to release the app, it could integrate the technology into future products, such as a noninvasive glucose monitor.

Get the Android app

Or read this on TechCrunch

Read more on:

Photo of Oura

Oura

Photo of Dexcom

Dexcom

Photo of medical device firm

medical device firm

Related news:

News photo

Oura Valued at $5 Billion in Deal With Glucose Device Maker Dexcom

News photo

Casio made an Oura Ring alternative that's everything but smart

News photo

Oura buys Sparta Science, its third acquisition in 2 years